Yasons Chemex Care Limited — Important, 12-11-2024: Financial Result Updates

Yasons Chemex Care Limited reported consolidated financials showing total revenue of ₹2,938.16 crore for the half-year ended September 30, 2024, down from ₹3,753.40 crore in the previous year, reflecting a reduction of approximately 22%. This decline could be attributed to decreased demand in key markets and ongoing operational challenges.

Net loss stood at ₹(187.76) crore compared to a profit of ₹281.90 crore year-over-year. The Earnings Per Share (EPS) figures were reported at ₹(1.06) against ₹1.62 last year, illustrating significant pressure on profitability.

Operational costs increased, primarily due to higher employee benefits and raw material costs, amounting to ₹2,767.70 crore, which may suggest inefficiencies or rising input costs impacting margins.

The balance sheet shows total assets of ₹6,160.51 crore, with a notable increase in current liabilities, indicating potential liquidity concerns. Cash flow from operating activities was negative at ₹(618.63) crore, further stressing operational cash generation issues.

In light of the current financial performance, the outlook remains cautious, with concerns over sustainability in demand and cost management. Thus, the overall guidance suggests a hold or watch approach for investors, assessing future recovery efforts.